摘要
目前全球的糖尿病患者约2亿，我国有糖尿病患者约5000万，并以每年120万人的数目递增。尽管全世界每年都在大力开发治疗糖尿病的新药，但直到目前，仍只有部分患者能获得满意的疗效，且需长期口服降糖药或注射胰岛素。国外研究结果显示即使接受了最强化的内科治疗，患者的糖化血红蛋白（HbAIc）仍维持在7．5％～8．5％之间。
出处
《中华内分泌外科杂志》
CAS
2011年第5期351-353,共3页
Chinese Journal of Endocrine Surgery
参考文献25
-
1Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial [ J ]. JAMA,2008,299 ( 3 ) : 316-323.
-
2Brancatisano A, Wahlroos S, Matthews S, et al. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese [ J ]. Surg Obes Relat Dis,2008,4(3 ) :423-429.
-
3Wickremese, kera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study[J]. Obes Surg,2005,15(4) : 474-481.
-
4Sjostrom L, Narbro K, Sjostrom D, et al. Effects of bariatric surgery on mortality in Swedish obese subjects[ J]. N Engi J Med, 2007,357 (8) :741-752.
-
5唐湘莲,蒋平.胃转流手术治疗2型糖尿病的新进展[c].第二届内分泌外科学术研讨会论文集.2009.7.24.
-
6Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 dia- betes[ J]. Ann Surg,2006,244(5 ) : 741-749.
-
7Lima J, Helena L, Oliveira S, et al. Rapid resolution of diabetes after gastric bypass [ J]. Obes Surg,2005,15 ( 3 ) : 448-449.
-
8Korner J, Bessler M, Cbilo LJ, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin [ J]. J Clin Endocrinol Metab, 2005,90( 1 ) : 359-365.
-
9Rizzello M, Abbatini F, Casella G, et al. Eady postoperative insu- lin-resistance changes alter sleeve gastrectolny [ J]. Obes Surg, 2010,20( 1 ) :50-55.
-
10Laferrere B, Heshka S, Wang K, et al. lncretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes [ J ]. Diabetes Care, 2007,30(7 ) : 1709 -1716.
二级参考文献31
-
1张新国,杨学军.手术治疗2型糖尿病的突破性进展[J].武警医学,2004,15(12):883-884. 被引量：60
-
2Cowan GS Jr, Buffinglon CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg, 1998, 22 : 987-992.
-
3Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatie diversion in patienls with morbid obesity. Obes Surg, 2007, 17 : 176-184.
-
4Rubino F, Gagner M. Potenlial of surgery for curing type 2 diabetes mellitus. Ann Surg, 2002, 236: 554-559.
-
5Scopinaro N, Papadia F, Marinari G, et al. Long-term control of type 2 diabetes mellitus and lhe other major components of the metabolic syndrome after biliopancreatic diversion in patienls with BMI <35 kg/m^2. Obes Surg, 2007, 17: 185-192.
-
6Pinkney J, Kerrigan D. Cunent status of bariatric surgery in the treatment of type 2 diabetes. Obes Rev, 2004, 5 : 69-78.
-
7Gan SS, Talbot ML, Jorgensen JO. Efficacy of surgery in the management of obesity-related type 2 diabetes mellitus. ANZ J Surg, 2007, 77: 958-962.
-
8Czupryniak L, Strzelczyk J, Cypryk K, et al. Gastric bypass surgery in severely obese type 1 diabetic patients. Diabetes Care, 2004. 27:2561-2562.
-
9Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg, 2004, 239: 1-11.
-
10Cummings DE, Overduin J, Foster- Schubert KE. Gastric bypass for obesity mecganisms of weight loss and diabetes resolution. J Clin Endocri Metab, 2004, 89: 2608-2615.
同被引文献25
-
1Zhen Li,Dong-Fei Li,Jing-Xing Dai,Yu Bai,Lin Yuan,Southern Medical University,Institute of Basic Medical Anatomy National Key Disciplines,Guangzhou 510515,Guangdong Province,China Hong-Ya Zhang,Lu-Xian Lv,Wen-Qiang Li,Second Affiliated Hospital,Xinxiang Medical College,Henan Province Key Laboratory of Biological Psychiatry,Xinxiang 453002,Henan Province,China Ou Sha,Department of Anatomy,Faculty of Medicine,Shenzhen University,Shenzhen 518060,Guangdong Province,China.Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of β-cells in Goto-Kakizaki rats[J].World Journal of Gastroenterology,2010,16(18):2244-2251. 被引量：14
-
2曹怡,邹大进.胃旁路术缓解2型糖尿病的机制[J].中华糖尿病杂志,2009,1(3). 被引量：5
-
3Via M A, Mechaniek J I. The role of bariatric surgery in the treatment of type 2 diabetes: current evidence and clinical guidelines[ J] .Curt Atheroscler Rep,2013,15( 11 ) :366.
-
4American Diabetes Association.Standards of medical care in diabetes-2009 [ J ].Diabetes Care, 2009,32 ( Suppl 1 ) : S 13- 16.
-
5Drucker D J. The role of gut hormones in glucose homeosta- sis[ J] .Clin Invest,2007,117( 1 ) :24-32.
-
6Maggard-Gibbons M, Maglione M, Livhits M, et al. Bari- atric surgery for weight loss and glycemic control in non- morbidly obese adults with diabetes: a systematic review [ J] .JAMA,2013,309( 21 ) :2250-2261.
-
7黄建萍,陈大灵.糖尿病的流行趋势及预防控制策略的研究进展[J].现代预防医学,2008,35(5):962-964. 被引量：71
-
8考晓明,胡志前,王强,张昱星.胃转流术对2型糖尿病大鼠血糖和GLP-1分泌的影响[J].肝胆胰外科杂志,2009,21(3):202-205. 被引量：10
-
9郭俊秀,武华,高彦斌.手术对糖尿病大鼠的降糖作用及其机制[J].中国药物与临床,2009,9(B07):25-26. 被引量：1
-
10王道荣,孙晓芳,赵长勇.Roux-en—Y胃旁路术与胃束带术对2型糖尿病的疗效比较及其机制[J].中华胃肠外科杂志,2009,12(6):630-631. 被引量：3
二级引证文献4
-
1孙栋,张光永,刘少壮,胡春晓,韩海峰,张翔,李明霞,胡三元.胃袖状切除术对2型糖尿病大鼠糖脂代谢的调控作用[J].中华消化外科杂志,2014,13(7):551-556. 被引量：4
-
2蔡逊,邵俊伟.胃转流术治疗2型糖尿病的研究新进展[J].华南国防医学杂志,2014,28(11):1157-1159. 被引量：1
-
3张刘兆,孙陟,张长乐.3种常见消化道重建方式对非肥胖型2型糖尿病患者疗效的Meta分析[J].安徽医学,2017,38(5):612-618. 被引量：3
-
4刘勇,马丹丹,邵俊伟,孙康,熊斌.胃袖状切除术联合空肠旁路术对2型糖尿病大鼠血糖及胰高血糖素样肽1表达的影响[J].华南国防医学杂志,2018,32(9):599-602. 被引量：4
-
1日发现胰岛素抵抗发病机理[J].国际医药卫生导报,2007,13(17):30-30.
-
2方伟钧.葛根素治疗糖尿病周围神经病变疗效观察[J].中国社区医师,2003,19(10):39-40. 被引量：1
-
3邓友江,张杰.医院获得性肺炎100例分析[J].职业卫生与病伤,2003,18(4):296-296.
-
4美国大力开发治疗心脏病和中风的药物[J].化工文摘,2001(5):47-47.
-
5王华,杨杰孚,张传宝,包承鑫,褚德发,钟优,李宏义,张瑞生,刘德平.慢性心力衰竭患者同型半胱氨酸水平改变的临床特点[J].中华老年心脑血管病杂志,2006,8(2):137-137. 被引量：15
-
6张阳东,董书魁,于敏,马盈盈,李雪丽.老年2型糖尿病患者糖化血红蛋白与血脂、高敏C反应蛋白相关性研究[J].中国老年学杂志,2005,25(10):1256-1257. 被引量：27
-
7苏珂,龙艳.老年Ⅱ型糖尿病患者血管并发症与生长激素、性激素水平的变化[J].中华老年医学杂志,1997,16(1):54-55. 被引量：1
-
8老年病学[J].国外科技资料目录（医药卫生）,2002(6):63-64.
-
9牟道华,谭正怀.Ⅱ型糖尿病动物模型研究进展[J].四川生理科学杂志,2010,32(4):172-174. 被引量：7
-
10美国ImmuneRegen公司开发“非典”疗法[J].上海医药,2003,24(6):287-287.
